by valethealth | Feb 9, 2021 | Press Release
Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”) announced positive results from the first patients treated in its COVID-19 clinical trial using stem cells licensed from and provided by Personalized Stem Cells, Inc. (PSC). The stem cell platform and FDA...
by valethealth | Jan 12, 2021 | Press Release
Performance Cell Manufacturing (PCM) recently completed a stem cell manufacturing contract for an FDA approved stem cell clinical trial for knee osteoarthritis. Manufacturing for the trial included processing adipose tissue (lipoaspirate) from 38 patients to produce...
by valethealth | Jan 8, 2021 | Press Release
Performance Cell Manufacturing (PCM), a contract development manufacturing organization division of VetStem Biopharma, announced that the facility they utilize for cGMP cell production is approved by the California Department of Public Health, Food and Drug Branch for...
by valethealth | Jan 8, 2021 | News & Events, Press Release
Performance Cell Manufacturing (PCM), a division of VetStem Biopharma, announced the opening of its expanded cGMP cell therapy manufacturing facility at its headquarters in Poway, California. PCM was born from VetStem’s 15 years of experience with cGMP compliant cell...
by valethealth | Jan 8, 2021 | Press Release
Performance Cell Manufacturing (PCM), a contract manufacturing organization division of VetStem Biopharma, has joined forces with leading human cancer therapy company, Calidi Biotherapeutics, to collaborate on a potential new cancer treatment. In a patented process,...
